TP53 and malignant colon neoplasm: In terms of mechanism, AURKA inhibits DNA damage responses in a TP53-dependent manner by inhibiting the expression of multiple DNA damage repair genes, which may partly explain ARUKA’s association with beneficial outcomes in colon cancer.